| Code | 98219 | ||||||||||
| MA number | 50/0233/92-CS | ||||||||||
| Product Form: | tbl 50x40 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 11.03.1992 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Furon 40 mg_tbl_08_2024.pdf
|
| PIL: |
PIL_Furon 40 mg_tbl_08_2024.pdf
|
| Safety feature | Yes |
| Data update: | 25.01.2018 |
